Investment
Features
FeesSafety
Academy
More
Pluang+

S&P 500 remains a Buy despite volatility, backed by strong earnings and AI-driven growth prospects.

Market News
18 Sep 2026
Seeking Alpha
View Source
Bullish
S&P 500 remains a Buy despite volatility, backed by strong earnings and AI-driven growth prospects.

The S&P 500 is rated a Buy as no recession is expected soon despite recent market volatility and Fed rate hikes. Q2 profits for the index surged over 50% year-over-year, supported by rising analyst estimates and peak AI capital expenditures. This strong earnings growth and operating leverage from expanded capacity are expected to drive significant free cash flow from 2028 onward. Current forward price-to-earnings ratios appear undervalued relative to profit growth, suggesting market pessimism is not justified.

The S&P 500's outlook is discussed here, with Pluang's market data providing context. For readers following US stocks, breadth shows 59 out of 150 priced stocks rose while 85 fell. Notable movers include NFLX at USD 72.74 with a -3.41% change, BABA at USD 110.99 up 2.27%, and BCS at USD 25.10 down 2.11%. This snapshot is as of Sep 18, 2026 19:01 WIB.

More News

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy's stock shows 8.26% upside with strong earnings forecast and mixed institutional interest.

Duke Energy Corporation's stock is projected to rise about 8.26% to a price target of $127, down slightly from $133, reflecting confidence despite a recent price dip. The company expects a 4.42% increase in earnings per share to $1.89 and a 3.86% ris...

Analyst Insights
Bullish
1 hour ago
Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals stock plunges 27.6% after pausing clinical trials due to safety concerns.

Xenon Pharmaceuticals halted new patient enrollment in its psychiatry clinical trials for the drug azetukalner after reports of neuropsychiatric side effects. This pause led to a sharp 27.6% drop in its stock price, marking its worst day since 2017. ...

Market News
Bearish
2 hours ago
Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma beats EPS estimates and secures $75M deal with Sobi, boosting cash runway to 2028

Innate Pharma reported an EPS of -$0.24, beating analyst estimates of -$0.29, and revenue of $6.5 million, slightly above expectations. The company secured a strategic partnership with Sobi for its drug lacutamab, receiving a $75 million upfront paym...

Company Fundamentals
Bullish
2 hours ago
Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex to report Q1 2027 earnings with expected EPS of $1.32 and $1.63B revenue on Sept 23

Paychex, a provider of human capital management solutions, will release its Q1 fiscal 2027 earnings on September 23, 2026. Analysts expect earnings per share (EPS) of $1.32, up from $1.22 last year, and revenue of about $1.63 billion, higher than las...

Company Fundamentals
Bullish
3 hours ago
Bitcoin surges past $80K as $183M in short bets liquidate, fueling a sharp price rally.

Bitcoin surges past $80K as $183M in short bets liquidate, fueling a sharp price rally.

Bitcoin's price surged from around $76,400 to nearly $81,000 on September 18, 2026, driven by a rapid liquidation of $192 million in leveraged crypto positions, including $183 million in short bets. This forced buying pushed Bitcoin above $80,000 for...

Market News
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App